Cardiac biomarkers should be measured in all patients who present with chest discomfort consistent with acute coronary syndrome (ACS). Elevations of cardiac enzyme levels should be interpreted in the context of clinical and ECG findings.1
This is a companion discussion topic for the original article at https://patient.info/doctor/cardiac-enzymes-and-markers-for-myocardial-infarction